Patents by Inventor Thomas Seidl
Thomas Seidl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260137312Abstract: A device for delivery of an insulin or insulin analog formulation and measurement of subcutaneous glucose concentration may comprise a hollow tube, and an amperometric glucose sensor located proximal to a distal end of the hollow tube. The amperometric glucose sensor may comprise a redox mediator and an enzyme comprising glucose oxidase or glucose dehydrogenase. An applied bias potential may allow an electrode layer of the amperometric glucose sensor to undergo substantially no electropolymerization of an excipient of the insulin or insulin analog formulation during continuous operation of amperometric glucose sensor. A sensitivity of the amperometric glucose sensor to the subcutaneous glucose concentration may be maintained in presence of the insulin or insulin analog formulation.Type: ApplicationFiled: November 18, 2025Publication date: May 21, 2026Inventors: William Kenneth Ward, Robert S. Cargill, Gabriel Heinrich, Sheila Benware, Mark Vreeke, Joseph D. Kowalski, Thomas Seidl
-
Patent number: 12611504Abstract: In an aspect, the present disclosure provides an insulin delivery device configured to be positioned on a body of a subject via a single puncture site in said body of said subject, wherein said insulin delivery device is configured to deliver an insulin or insulin analog formulation to said subject via said single puncture site, wherein said insulin delivery device comprises a sensor configured to measure a glucose concentration in said body of said subject via said single puncture site, and wherein said delivering and said measuring are performed at substantially the same time for a time period of at least 1 hour subsequent to said positioning, while maintaining a sensitivity of said sensor of at least 50% of an initial sensitivity of said sensor.Type: GrantFiled: June 24, 2025Date of Patent: April 28, 2026Assignee: PACIFIC DIABETES TECHNOLOGIES, INC.Inventors: William Kenneth Ward, Robert S. Cargill, Gabriel Heinrich, Sheila Benware, Mark Vreeke, Joseph D. Kowalski, Thomas Seidl
-
Publication number: 20260004583Abstract: A computing system receives a plurality of game files corresponding to a plurality of games across a plurality of seasons. The computing system generates a prediction model configured to generate a possession value for an event. The computing system receives a target event, in real-time or near real-time, from a tracking system monitoring a target game. The computing system generates target features for the target event based on target event data associated with the target event. The computing system generates, via the prediction model, a target possession value for the target event based on the target event data and the target features. The target possession value represents a likelihood that a team with possession will score within a following x-seconds after the target event.Type: ApplicationFiled: July 17, 2025Publication date: January 1, 2026Applicant: STATS LLCInventors: Michael Stöckl, Patrick Joseph Lucey, Daniel Dinsdale, Thomas Seidl, Paul David Power, Nils Sebastiaan Mackaij, Joe Dominic GALLAGHER
-
Publication number: 20260000831Abstract: The disclosure describes devices and methods for insertion and delivery of insulin or an insulin analog formulation and measurement of subcutaneous glucose concentration. A device for delivery of insulin or an insulin analog formulation and measurement of subcutaneous glucose concentration, may comprise: (a) a tube comprising a proximal end and a distal end, wherein the proximal end is in fluid communication with a source of the insulin or insulin analog formulation, and wherein the distal end is configured to deliver the insulin or insulin analog formulation subcutaneously; (b) a glucose sensor disposed along a central axis of the tube; and (c) a penetrating body disposed along the central axis of the tube, wherein the penetrating body comprises a cross-sectional area no more than a cross-sectional area of the glucose sensor.Type: ApplicationFiled: July 14, 2025Publication date: January 1, 2026Inventors: Thomas SEIDL, Solomon REID
-
Patent number: 12495995Abstract: A device for delivery of an insulin or insulin analog formulation and measurement of subcutaneous glucose concentration may comprise a hollow tube, and an amperometric glucose sensor located proximal to a distal end of the hollow tube. The amperometric glucose sensor may comprise a redox mediator and an enzyme comprising glucose oxidase or glucose dehydrogenase. An applied bias potential may allow an electrode layer of the amperometric glucose sensor to undergo substantially no electropolymerization of an excipient of the insulin or insulin analog formulation during continuous operation of amperometric glucose sensor. A sensitivity of the amperometric glucose sensor to the subcutaneous glucose concentration may be maintained in presence of the insulin or insulin analog formulation.Type: GrantFiled: February 22, 2023Date of Patent: December 16, 2025Assignee: PACIFIC DIABETES TECHNOLOGIES, INCInventors: William Kenneth Ward, Robert S. Cargill, Gabriel Heinrich, Sheila Benware, Mark Vreeke, Joseph D. Kowalski, Thomas Seidl
-
Patent number: 12478734Abstract: A method may comprise (a) inserting an insulin delivery device subcutaneously into a body of a subject, which comprises an amperometric glucose sensor comprising an electrode layer comprising an indicating electrode and underlying a redox-catalytic layer comprising a redox mediator; (b) using said insulin delivery device to deliver an insulin formulation (e.g., comprising a phenol or cresol excipient) subcutaneously to said subject; and (c) using said amperometric glucose sensor to measure a subcutaneous glucose concentration, which comprises using said redox-catalytic layer to allow electron transfer from subcutaneous glucose to said indicating electrode sufficient to cause a response of said amperometric glucose sensor at an applied bias potential of no more than +250 millivolts, wherein (b) and (c) are performed at the same time for at least one hour, while maintaining a sensor sensitivity of at least 50% of an initial sensor sensitivity for up to one hour.Type: GrantFiled: June 24, 2025Date of Patent: November 25, 2025Assignee: PACIFIC DIABETES TECHNOLOGIES INC.Inventors: William Kenneth Ward, Robert S. Cargill, Gabriel Heinrich, Sheila Benware, Mark Vreeke, Joseph D. Kowalski, Thomas Seidl
-
Publication number: 20250319256Abstract: In an aspect, the present disclosure provides an insulin delivery device configured to be positioned on a body of a subject via a single puncture site in said body of said subject, wherein said insulin delivery device is configured to deliver an insulin or insulin analog formulation to said subject via said single puncture site, wherein said insulin delivery device comprises a sensor configured to measure a glucose concentration in said body of said subject via said single puncture site, and wherein said delivering and said measuring are performed at substantially the same time for a time period of at least 1 hour subsequent to said positioning, while maintaining a sensitivity of said sensor of at least 50% of an initial sensitivity of said sensor.Type: ApplicationFiled: June 24, 2025Publication date: October 16, 2025Inventors: William Kenneth WARD, Robert S. CARGILL, Gabriel HEINRICH, Sheila BENWARE, Mark VREEKE, Joseph D. KOWALSKI, Thomas SEIDL
-
Publication number: 20250319255Abstract: A method may comprise (a) inserting an insulin delivery device subcutaneously into a body of a subject, which comprises an amperometric glucose sensor comprising an electrode layer comprising an indicating electrode and underlying a redox-catalytic layer comprising a redox mediator; (b) using said insulin delivery device to deliver an insulin formulation (e.g., comprising a phenol or cresol excipient) subcutaneously to said subject; and (c) using said amperometric glucose sensor to measure a subcutaneous glucose concentration, which comprises using said redox-catalytic layer to allow electron transfer from subcutaneous glucose to said indicating electrode sufficient to cause a response of said amperometric glucose sensor at an applied bias potential of no more than +250 millivolts, wherein (b) and (c) are performed at the same time for at least one hour, while maintaining a sensor sensitivity of at least 50% of an initial sensor sensitivity for up to one hour.Type: ApplicationFiled: June 24, 2025Publication date: October 16, 2025Inventors: William Kenneth WARD, Robert S. CARGILL, Gabriel HEINRICH, Sheila BENWARE, Mark VREEKE, Joseph D. KOWALSKI, Thomas SEIDL
-
Patent number: 12400446Abstract: A computing system receives a plurality of game files corresponding to a plurality of games across a plurality of seasons. The computing system generates a prediction model configured to generate a possession value for an event. The computing system receives a target event, in real-time or near real-time, from a tracking system monitoring a target game. The computing system generates target features for the target event based on target event data associated with the target event. The computing system generates, via the prediction model, a target possession value for the target event based on the target event data and the target features. The target possession value represents a likelihood that a team with possession will score within a following x-seconds after the target event.Type: GrantFiled: July 14, 2022Date of Patent: August 26, 2025Assignee: STATS LLCInventors: Michael Stöckl, Patrick Joseph Lucey, Daniel Dinsdale, Thomas Seidl, Paul David Power, Nils Sebastiaan Mackaij, Joe Dominic Gallagher
-
Patent number: 12383675Abstract: In an aspect, the present disclosure provides a method comprising: (a) positioning an insulin delivery device on a body of a subject via a single puncture site in said body of said subject; (b) using said insulin delivery device to deliver an insulin or insulin analog formulation to said subject via said single puncture site; and (c) using a sensor of said insulin delivery device to measure a glucose concentration in said body of said subject via said single puncture site, wherein (b) and (c) are performed at substantially the same time for a time period of at least 1 hour subsequent to said positioning in (a), while maintaining a sensitivity of said sensor of at least 50% of an initial sensitivity of said sensor.Type: GrantFiled: October 7, 2024Date of Patent: August 12, 2025Assignee: Pacific Diabetes Technologies IncInventors: William Kenneth Ward, Robert S. Cargill, Gabriel Heinrich, Sheila Benware, Mark Vreeke, Joseph D. Kowalski, Thomas Seidl
-
Publication number: 20250228480Abstract: Methods and devices useful for determining the analyte concentration of a sample using output currents obtained from an input potential in the kinetic potential region of a redox mediator are disclosed. Preferably, the input potential used to generate the output currents from the kinetic potential region of the redox mediator is continually increasing with time after initiating the analysis. A method of selecting an initial input potential within the kinetic potential region of a redox mediator based on the sensitivity of an individual or batch of subcutaneously insertable test sensors also is described. A method of selecting an analysis input potential within the kinetic potential region of redox mediator based on the sensitivity of an individual subcutaneously inserted test sensor also is described where the analysis input potential is increased with insertion time.Type: ApplicationFiled: January 7, 2025Publication date: July 17, 2025Applicant: Pacific Diabetes Technologies, Inc.Inventors: Thomas Seidl, William Kenneth Ward, Huan-Ping Wu
-
Publication number: 20250218002Abstract: A computing system identifies player tracking data and event data corresponding to a match. The match includes a first team and a second team. The player tracking data includes coordinate positions of each player during the event. The event data defines events that occur during the match. The computing system divides the player tracking data into a plurality of segments based on the event information. For each segment of the plurality of segments, the computing system learns a first formation associated with a respective team in possession. For each segment of the plurality of segments, the computing system learns a second formation associated with a respective team not in possession. The computing system maps each first formation to a first class of known formation clusters. The computing system maps each second formation to a second class of known formation clusters.Type: ApplicationFiled: March 24, 2025Publication date: July 3, 2025Applicant: STATS LLCInventors: Thomas Seidl, Michael Stöckl, Patrick Joseph Lucey
-
Patent number: 12283056Abstract: A computing system identifies player tracking data and event data corresponding to a match. The match includes a first team and a second team. The player tracking data includes coordinate positions of each player during the event. The event data defines events that occur during the match. The computing system divides the player tracking data into a plurality of segments based on the event information. For each segment of the plurality of segments, the computing system learns a first formation associated with a respective team in possession. For each segment of the plurality of segments, the computing system learns a second formation associated with a respective team not in possession. The computing system maps each first formation to a first class of known formation clusters. The computing system maps each second formation to a second class of known formation clusters.Type: GrantFiled: February 11, 2022Date of Patent: April 22, 2025Assignee: STATS LLCInventors: Thomas Seidl, Michael Stöckl, Patrick Joseph Lucey
-
Patent number: 12216074Abstract: Methods and devices useful for determining the analyte concentration of a sample using output currents obtained from an input potential in the kinetic potential region of a redox mediator are disclosed. Preferably, the input potential used to generate the output currents from the kinetic potential region of the redox mediator is continually increasing with time after initiating the analysis. A method of selecting an initial input potential within the kinetic potential region of a redox mediator based on the sensitivity of an individual or batch of subcutaneously insertable test sensors also is described. A method of selecting an analysis input potential within the kinetic potential region of redox mediator based on the sensitivity of an individual subcutaneously inserted test sensor also is described where the analysis input potential is increased with insertion time.Type: GrantFiled: September 29, 2022Date of Patent: February 4, 2025Assignee: Pacific Diabetes Technologies, Inc.Inventors: Thomas Seidl, William Kenneth Ward, Huan-Ping Wu
-
Publication number: 20240094156Abstract: Methods and devices useful for determining the analyte concentration of a sample using output currents obtained from an input potential in the kinetic potential region of a redox mediator are disclosed. Preferably, the input potential used to generate the output currents from the kinetic potential region of the redox mediator is continually increasing with time after initiating the analysis. A method of selecting an initial input potential within the kinetic potential region of a redox mediator based on the sensitivity of an individual or batch of subcutaneously insertable test sensors also is described. A method of selecting an analysis input potential within the kinetic potential region of redox mediator based on the sensitivity of an individual subcutaneously inserted test sensor also is described where the analysis input potential is increased with insertion time.Type: ApplicationFiled: September 29, 2022Publication date: March 21, 2024Applicant: Pacific Diabetes Technologies, Inc.Inventors: Thomas Seidl, William Kenneth Ward, Huan-Ping Wu
-
Publication number: 20230329593Abstract: A device for delivery of an insulin or insulin analog formulation and measurement of subcutaneous glucose concentration may comprise a hollow tube, and an amperometric glucose sensor located proximal to a distal end of the hollow tube. The amperometric glucose sensor may comprise a redox mediator and an enzyme comprising glucose oxidase or glucose dehydrogenase. An applied bias potential may allow an electrode layer of the amperometric glucose sensor to undergo substantially no electropolymerization of an excipient of the insulin or insulin analog formulation during continuous operation of amperometric glucose sensor. A sensitivity of the amperometric glucose sensor to the subcutaneous glucose concentration may be maintained in presence of the insulin or insulin analog formulation.Type: ApplicationFiled: February 22, 2023Publication date: October 19, 2023Inventors: William Kenneth Ward, Robert S. Cargill, Gabriel Heinrich, Sheila Benware, Mark Vreeke, Joseph D. Kowalski, Thomas Seidl
-
Publication number: 20230328220Abstract: The present invention relates to a system and method for capturing video of a real-world scene over a field of view that may exceed the field of view of a user, manipulating the captured video, and then stereoscopically displaying the manipulated image to the user in a head mounted display to create a virtual environment having length, width, and depth in the image. By capturing and manipulating video for a field of view that exceeds the field of view of the user, the system and method can quickly respond to movement by the user to update the display allowing the user to look and pan around, i.e., navigate, inside the three-dimensional virtual environment.Type: ApplicationFiled: November 11, 2022Publication date: October 12, 2023Inventors: Thomas Seidl, Ron Igra
-
Publication number: 20230320629Abstract: By combining analyte concentration monitoring electrodes and infusion functions into a single subcutaneous element, the described sensing cannulae having a rectangular cross-section avoids the need for two separate devices for insulin delivery and glucose concentration determination. The substantially flat, thus planar, surface of the sensing cannula provides a substrate for deposition of one or more sensing electrodes, preferably through a lithographic-type process. The inner lumen of the sensing cannula serves as a conduit for drug delivery and is formed in a manner that is compatible with lithographic-type electrode formation. The rectangular cross-section of the sensing cannula also allows face and side ports establishing fluid communication between the inner lumen and tissue that preferably reduces the incidence of occlusion of the inner lumen of the sensing cannula.Type: ApplicationFiled: April 10, 2023Publication date: October 12, 2023Applicant: Pacific Diabetes Technologies, Inc.Inventors: Thomas Seidl, William Kenneth Ward, Florian Guillot, Brennen McCullough, Chad Knutsen, Robert S Cargill, Scott M. Vanderwerf, Matt Breen
-
Publication number: 20230031622Abstract: A computing system receives a plurality of game files corresponding to a plurality of games across a plurality of seasons. The computing system generates a prediction model configured to generate a possession value for an event. The computing system receives a target event, in real-time or near real-time, from a tracking system monitoring a target game. The computing system generates target features for the target event based on target event data associated with the target event. The computing system generates, via the prediction model, a target possession value for the target event based on the target event data and the target features. The target possession value represents a likelihood that a team with possession will score within a following x-seconds after the target event.Type: ApplicationFiled: July 14, 2022Publication date: February 2, 2023Applicant: STATS LLCInventors: Michael Stöckl, Patrick Joseph Lucey, Daniel Dinsdale, Thomas Seidl, Paul David Power, Nils Sebastiaan Mackaij, Joe Dominic Gallagher
-
Patent number: 11528468Abstract: The present invention relates to a system and method for capturing video of a real-world scene over a field of view that may exceed the field of view of a user, manipulating the captured video, and then stereoscopically displaying the manipulated image to the user in a head mounted display to create a virtual environment having length, width, and depth in the image. By capturing and manipulating video for a field of view that exceeds the field of view of the user, the system and method can quickly respond to movement by the user to update the display allowing the user to look and pan around, i.e., navigate, inside the three-dimensional virtual environment.Type: GrantFiled: January 26, 2021Date of Patent: December 13, 2022Assignee: SHAREVR HAWAII LLCInventors: Thomas Seidl, Ron Igra